Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Capricor Therapeutics (CAPR) Times Interest Earned (2016 - 2017)

Capricor Therapeutics has reported Times Interest Earned over the past 7 years, most recently at -$40.85 for Q4 2017.

  • Quarterly results put Times Interest Earned at -$40.85 for Q4 2017, down 44.29% from a year ago — trailing twelve months through Sep 2018 was -$190.54 (down 542.59% YoY), and the annual figure for FY2025 was -$35.51, changed.
  • Times Interest Earned for Q4 2017 was -$40.85 at Capricor Therapeutics, down from -$24.5 in the prior quarter.
  • Over the last five years, Times Interest Earned for CAPR hit a ceiling of -$24.5 in Q3 2017 and a floor of -$385.96 in Q1 2013.
  • Median Times Interest Earned over the past 5 years was -$48.22 (2014), compared with a mean of -$74.87.
  • Biggest five-year swings in Times Interest Earned: surged 89.59% in 2014 and later tumbled 87.0% in 2015.
  • Capricor Therapeutics' Times Interest Earned stood at -$63.98 in 2013, then soared by 61.37% to -$24.71 in 2014, then plummeted by 109.04% to -$51.66 in 2015, then soared by 45.2% to -$28.31 in 2016, then tumbled by 44.29% to -$40.85 in 2017.
  • The last three reported values for Times Interest Earned were -$40.85 (Q4 2017), -$24.5 (Q3 2017), and -$32.02 (Q2 2017) per Business Quant data.